Susquehanna International Group’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.76M | Buy |
126,023
+16,039
| +15% | +$224K | ﹤0.01% | 2446 |
|
2025
Q1 | $1.48M | Buy |
109,984
+14,119
| +15% | +$190K | ﹤0.01% | 2717 |
|
2024
Q4 | $1.84M | Buy |
95,865
+19,956
| +26% | +$383K | ﹤0.01% | 2098 |
|
2024
Q3 | $1.73M | Buy |
75,909
+26,698
| +54% | +$607K | ﹤0.01% | 2005 |
|
2024
Q2 | $640K | Sell |
49,211
-5,229
| -10% | -$68K | ﹤0.01% | 3162 |
|
2024
Q1 | $953K | Buy |
54,440
+29,122
| +115% | +$510K | ﹤0.01% | 2712 |
|
2023
Q4 | $551K | Sell |
25,318
-6,329
| -20% | -$138K | ﹤0.01% | 3716 |
|
2023
Q3 | $485K | Sell |
31,647
-178,349
| -85% | -$2.74M | ﹤0.01% | 3446 |
|
2023
Q2 | $5M | Buy |
209,996
+117,670
| +127% | +$2.8M | ﹤0.01% | 1145 |
|
2023
Q1 | $2.35M | Buy |
92,326
+76,822
| +495% | +$1.95M | ﹤0.01% | 1785 |
|
2022
Q4 | $453K | Sell |
15,504
-8,782
| -36% | -$257K | ﹤0.01% | 3361 |
|
2022
Q3 | $498K | Sell |
24,286
-62,968
| -72% | -$1.29M | ﹤0.01% | 3550 |
|
2022
Q2 | $1.01M | Sell |
87,254
-10,273
| -11% | -$119K | ﹤0.01% | 2447 |
|
2022
Q1 | $1.8M | Buy |
+97,527
| New | +$1.8M | ﹤0.01% | 2125 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 6499 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 6145 |
|
2020
Q2 | – | Sell |
-3,014
| Closed | -$20K | – | 4993 |
|
2020
Q1 | $20K | Buy |
+3,014
| New | +$20K | ﹤0.01% | 4350 |
|
2019
Q3 | – | Sell |
-747
| Closed | -$23K | – | 5073 |
|
2019
Q2 | $23K | Buy |
+747
| New | +$23K | ﹤0.01% | 4350 |
|
2017
Q2 | – | Sell |
-946
| Closed | -$177K | – | 4416 |
|
2017
Q1 | $177K | Buy |
+946
| New | +$177K | ﹤0.01% | 2868 |
|
2016
Q3 | – | Sell |
-120
| Closed | -$11K | – | 4013 |
|
2016
Q2 | $11K | Buy |
+120
| New | +$11K | ﹤0.01% | 3098 |
|
2015
Q2 | – | Sell |
-69
| Closed | -$34K | – | 4766 |
|
2015
Q1 | $34K | Buy |
+69
| New | +$34K | ﹤0.01% | 3982 |
|